Tibsovo and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Tibsovo (ivosidenib), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Zofran, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Joint pain when taking Tibsovo. It is created by eHealthMe based on reports of 1,419 people who have side effects when taking Tibsovo from the FDA, and is updated regularly.

What is Tibsovo?

Tibsovo has active ingredients of ivosidenib. eHealthMe is studying from 1,420 Tibsovo users. Check the latest studies of Tibsovo.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 19, 2026

1,419 people reported to have side effects when taking Tibsovo.
Among them, 48 people (3.38%) have Joint pain.

Among these 48 people:

How long have people been on Tibsovo when they have Joint pain? *

What is the gender of people who have Joint pain when taking Tibsovo? *

female: 50 %
male: 50 %

What is the age of people who have Joint pain when taking Tibsovo? *

What are other drugs people take besides Tibsovo? *

What are other side effects people have besides Joint pain? *

Pain: 10 people, 20.83%
Fatigue (feeling of tiredness): 9 people, 18.75%
Nausea (feeling of having an urge to vomit): 8 people, 16.67%
Diarrhea: 7 people, 14.58%
Tinnitus (a ringing in the ears): 6 people, 12.50%
Dyspnea (difficult or laboured breathing): 5 people, 10.42%
Joint Swelling: 4 people, 8.33%
Swelling: 4 people, 8.33%
Muscle Aches (muscle pain): 4 people, 8.33%
Haemoglobin Abnormal: 4 people, 8.33%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 16 people, 33.33%
Brain Neoplasm Malignant (brain cancer tumour): 10 people, 20.83%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 9 people, 18.75%
Pain: 2 people, 4.17%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 4.17%
Depression: 2 people, 4.17%
Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 2 people, 4.17%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 2.08%
Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 2.08%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Tibsovo and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tibsovo:

Tibsovo (1,420 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Tibsovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,331 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ivosidenib (the active ingredients of Tibsovo) and Tibsovo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.